Reduction of aromatic and heterocyclic aromatic N -hydroxylamines by human cytochrome P450 2S1

Chemical Research in Toxicology

Volumn 26, Issue 6, 2013, Pages 993-1004

  Wang, Kai ^a   Guengerich, F Peter ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 FLUORENYLAMINE; 2 NAPHTHYLAMINE; 4 BIPHENYLAMINE; AROMATIC AMINE; CYTOCHROME P450; CYTOCHROME P450 2S1; FLUORENE; HETEROCYCLIC AROMATIC AMINE; HYDROXYLAMINE; N HYDROXYPHENACETIN; NAPHTHALENE; UNCLASSIFIED DRUG; CYP2S1 PROTEIN, HUMAN; HETEROCYCLIC COMPOUND;

ARTICLE; BIOTRANSFORMATION; CHEMICAL STRUCTURE; OXIDATION; CHEMISTRY; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION;

ANIMALIA;

CYTOCHROME P-450 ENZYME SYSTEM; HETEROCYCLIC COMPOUNDS; HUMANS; HYDROXYLAMINES; MOLECULAR STRUCTURE; OXIDATION-REDUCTION;

EID: 84879131366     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx400139p     Document Type: Article

References (89)

1. Guengerich, F. P. (2001) Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity Chem. Res. Toxicol. 14, 611-650
2. Guengerich, F. P. (2008) Cytochrome P450 and chemical toxicology Chem. Res. Toxicol. 21, 70-83
3. i/AUC ratios Drug Metab. Dispos. 32, 1201-1208
4. Wienkers, L. C. and Heath, T. G. (2005) Predicting in vivo drug interactions from in vitro drug discovery data Nat. Rev. Drug Discovery 4, 825-833
5. Rendic, S. and Guengerich, F. P. (2012) Contributions of human enzymes in carcinogen metabolism Chem. Res. Toxicol. 25, 1316-1383
6. Radomski, J. L. (1979) Primary aromatic amines: Their biological properties and structure-activity relationships Annu. Rev. Pharmacol. Toxicol. 19, 129-157
7. Kim, D. and Guengerich, F. P. (2005) Cytochrome P450 activation of arylamines and heterocyclic amines Annu. Rev. Pharmacol. Toxicol. 45, 27-49
8. Rehn, L. (1895) Über Blasentumoren bei Fuchsinarbeitern Archives of Clinical Chirgurie 50, 588-600
9. Kriek, E. (1974) Carcinogenesis by aromatic amines Biochim. Biophys. Acta 355, 177-203
10. Heflich, R. H. and Neft, R. E. (1994) Genetic toxicity of 2-acetylaminofluorene, 2-aminofluorene and some of their metabolites and model metabolites Mutat. Res. 318, 73-174
11. Verna, L., Whysner, J., and Williams, G. M. (1996) 2-Acetylaminofluorene mechanistic data and risk assessment: DNA reactivity, enhanced cell proliferation and tumor initiation Pharmacol. Ther. 71, 83-105
12. Sugimura, T., Wakabayashi, K., Nakagama, H., and Nagao, M. (2004) Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish Cancer Sci. 95, 290-299
13. Turesky, R. J. and Le Marchand, L. (2011) Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: Lessons learned from aromatic amines Chem. Res. Toxicol. 24, 1169-1214
14. Manabe, S., Suzuki, H., Wada, O., and Ueki, A. (1993) Detection of the carcinogen 2-amino-1-methyl-6-phenyl-imidazo[4,5-b ]pyridine (PhIP) in beer and wine Carcinogenesis 14, 899-901
15. Matsumoto, T., Yoshida, D., and Tomita, H. (1981) Determination of mutagens, amino-α-carbolines in grilled foods and cigarette-smoke condensate Cancer Lett. 12, 105-110
16. Manabe, S., Tohyama, K., Wada, O., and Aramaki, T. (1991) Detection of a carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b ]pyridine (PhIP), in cigarette smoke condensate Carcinogenesis 12, 1945-1947
17. Murkovic, M. (2004) Formation of heterocyclic aromatic amines in model systems J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 802, 3-10
18. Eisenbrand, G. and Tang, W. (1993) Food-borne heterocyclic amines. Chemistry, formation, occurrence and biological activities. A literature review Toxicology 84, 1-82
19. Sugimura, T., Nagao, M., and Kawachi, T. (1977) Mutagens-carcinogens in foods, with special reference to highly mutagenic pyrolytic products in broiled foods. In Origins of Human Cancer (Hiatt, H. H., Watson, J. D., and Winsten, J. A., Eds.) pp 1561-1577, Cold Spring Harbor Laboratory Press, Plainview, NY.
20. Nagao, M., Sugimura, T., and Matsushima, T. (1978) Environmental mutagens and carcinogens Annu. Rev. Genet. 12, 117-159
21. Sugimura, T. (1986) Studies on environmental chemical carcinogenesis in Japan Science 233, 312-318
22. Nagao, M. and Sugimura, T. (1993) Carcinogenic factors in food with relevance to colon cancer development Mutat. Res. 290, 43-51
23. Sugimura, T. (1997) Overview of carcinogenic heterocyclic amines Mutat. Res. 376, 211-219
24. PA (P-450 1A2), the phenacetin O -deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N -oxidation of carcinogenic arylamines Proc. Natl. Acad. Sci. U.S.A. 86, 7696-7700
25. Shimada, T. and Guengerich, F. P. (1991) Activation of amino-α-carboline, 2-amino-1-methyl-6-phenylimidazo[4,5-b ]pyridine, and a copper phthalocyanine cellulose extract of cigarette smoke condensate by cytochrome P-450 enzymes in rat and human liver microsomes Cancer Res. 51, 5284-5291
26. Guengerich, F. P. and Shimada, T. (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes Chem. Res. Toxicol. 4, 391-407
27. Turesky, R. J. (2002) Heterocyclic aromatic amine metabolism, DNA adduct formation, mutagenesis, and carcinogenesis Drug Metab. Rev. 34, 625-650
28. Miller, E. C. (1978) Some current perspectives on chemical carcinogenesis in humans and experimental animals: Presidential address Cancer Res. 38, 1479-1496
29. Humphreys, W. G., Kadlubar, F. F., and Guengerich, F. P. (1992) Mechanism of C8 alkylation of guanine residues by activated arylamines: Evidence for initial adduct formation at the N7 position Proc. Natl. Acad. Sci. U.S.A. 89, 8278-8282
30. Butler, M. A., Guengerich, F. P., and Kadlubar, F. F. (1989) Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4′-methylene-bis(2- chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases Cancer Res. 49, 25-31
31. Shimada, T., Iwasaki, M., Martin, M. V., and Guengerich, F. P. (1989) Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA1535/pSK1002 Cancer Res. 49, 3218-3228
32. Wallin, H., Mikalsen, A., Guengerich, F. P., Ingelman-Sundberg, M., Solberg, K. E., Rossland, O. J., and Alexander, J. (1990) Different rates of metabolic activation and detoxication of the food mutagen 2-amino-1-methyl-6- phenylimidazo(4,5-f)pyridine by different cytochrome P-450 enzymes Carcinogenesis 11, 489-492
33. Rich, K. J., Murray, B. P., Lewis, I., Rendell, N. B., Davies, D. S., Gooderham, N. J., and Boobis, A. R. (1992) N -Hydroxy-MeIQx is the major microsomal oxidation product of the dietary carcinogen MeIQx with human liver Carcinogenesis 13, 2221-2226
34. Frandsen, H., Nielsen, P. A., Grivas, S., and Larsen, J. C. (1994) Microsomal metabolism of the food mutagen 2-amino-3,4,8-trimethyl-3 H -imidazo[4,5-f ]-quinoxaline to mutagenic metabolites Mutagenesis 9, 59-65
35. Hammons, G. J., Milton, D., Stepps, K., Guengerich, F. P., Tukey, R. H., and Kadlubar, F. F. (1997) Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes Carcinogenesis 18, 851-854
36. Shimada, T., Hayes, C. L., Yamazaki, H., Amin, S., Hecht, S. S., Guengerich, F. P., and Sutter, T. R. (1996) Activation of chemically diverse procarcinogens by human cytochrome P450 1B1 Cancer Res. 56, 2979-2984
37. Nebert, D. W., Dalton, T. P., Okey, A. B., and Gonzalez, F. J. (2004) Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer J. Biol. Chem. 279, 23847-23850
38. Guengerich, F. P. (2005) Human cytochrome P450 enzymes. In Cytochrome P450: Structure, Mechanism, and Biochemisty (Ortiz de Montellano, P. R., Ed.) 3rd ed., pp 377-530, Kluwer Academic/Plenum Press, New York.
39. Ding, X. and Kaminsky, L. S. (2003) Human extrahepatic cytochromes P450: Function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts Annu. Rev. Pharmacol. Toxicol. 43, 149-173
40. Hammons, G. J., Dooley, K. L., and Kadlubar, F. F. (1991) 4-Aminobiphenyl-hemoglobin adduct formation as an index of in vivo N -oxidation by hepatic cytochrome P-450 1A2 Chem. Res. Toxicol. 4, 144-147
41. Boobis, A. R., Lynch, A. M., Murray, S., de la Toore, R., Solans, A., Farré, M., Segura, J., Gooderham, N. J., and Davies, D. S. (1994) CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in huamns Cancer Res. 54, 89-94
42. Guengerich, F. P. and Cheng, Q. (2011) Orphans in the human cytochrome P450 superfamily: Approaches to discovering functions and relevance in pharmacology Pharmacol. Rev. 63, 684-699
43. Rylander, T., Neve, E. P. A., Ingelman-Sundberg, M., and Oscarson, M. (2001) Identification and tissue distribution of the novel human cytochrome P450 2S1 (CYP2S1) Biochem. Biophys. Res. Commun. 281, 529-535
44. Smith, G., Wolf, C. R., Deeni, Y. Y., Dawe, R. S., Evans, A. T., Comrie, M. M., Ferguson, J., and Ibbotson, S. H. (2003) Cutaneous expression of cytochrome P450 CYP2S1: Individuality in regulation by therapeutic agents for psoriasis and other skin diseases Lancet 361, 1336-1343
45. Saarikoski, S. T., Rivera, S. P., Hankinson, O., and Husgafvel- Pursiainen, K. (2005) CYP2S1: A short review Toxicol. Appl. Pharmacol. 207, 62-69
46. Saarikoski, S. T., Wikman, H. A., Smith, G., Wolff, C. H., and Husgafvel-Pursiainen, K. (2005) Localization of cytochrome P450 CYP2S1 expression in human tissues by in situ hybridization and immunohistochemistry J. Histochem. Cytochem. 53, 549-556
47. Rivera, S. P., Saarikoski, S. T., and Hankinson, O. (2002) Identification of a novel dioxin-inducible cytochrome P450 Mol. Pharmacol. 61, 255-259
48. Rivera, S. P., Wang, F., Saarikoski, S. T., Taylor, R. T., Chapman, B., Zhang, R., and Hankinson, O. (2007) A novel promoter element containing multiple overlapping xenobiotic and hypoxia response elements mediates induction of cytochrome P450 2S1 by both dioxin and hypoxia J. Biol. Chem. 282, 10881-10893
49. Madanayake, T. W., Fidler, T. P., Fresquez, T. M., Bajaj, N., and Rowland, A. M. (2012) Cytochrome P450 2S1 depletion enhances cell proliferation and migration in bronchial epithelial cells, in part, through modulation of prostaglandin E-2 synthesis Drug Metab. Dispos. 40, 2119-2125
50. Wu, Z. L., Sohl, C. D., Shimada, T., and Guengerich, F. P. (2006) Recombinant enzymes overexpressed in bacteria show broad catalytic specificity of human cytochrome P450 2W1 and limited activity of human cytochrome P450 2S1 Mol. Pharmacol. 69, 2007-2014
51. Nishida, C. R., Lee, M., and Ortiz de Montellano, P. R. (2010) Efficient hypoxic activation of the anticancer agent AQ4N by CYP2S1 and CYP2W1 Mol. Pharmacol. 78, 497-502
52. Xiao, Y., Shinkyo, R., and Guengerich, F. P. (2011) Cytochrome P450 2S1 is reduced by NADPH-cytochrome P450 reductase Drug Metab. Dispos. 39, 944-946
53. Wang, K. and Guengerich, F. P. (2012) Bioactivation of fluorinated 2-aryl-benzothiazole antitumor molecules by human cytochrome P450s 1A1 and 2W1 and deactivation by cytochrome P450 2S1 Chem. Res. Toxicol. 25, 1740-1751
54. Hinson, J. A. and Mitchell, J. R. (1976) N -Hydroxylation of phenacetin by hamster liver microsomes Drug Metab. Dispos. 4, 430-435
55. Wirth, P. J., Dybing, E., von Bahr, C., and Thorgeirsson, S. S. (1980) Mechanism of N -hydroxyacetylarylamine mutagenicity in the Salmonella test system: Metabolic activation of N -hydroxyphenacetin by liver and kidney fractions from rat, mouse, hamster, and man Mol. Pharmacol. 18, 117-127
56. Westra, J. G. (1981) A rapid and simple synthesis of reactive metabolites of carcinogenic aromatic amines in high yield Carcinogenesis 2, 355-357
57. Turesky, R. J., Lang, N. P., Butler, M. A., Teitel, C. H., and Kadlubar, F. F. (1991) Metabolic-activation of carcinogenic heterocyclic aromatic amines by human liver and colon Carcinogenesis 12, 1839-1845
58. Hanna, I. H., Teiber, J. F., Kokones, K. L., and Hollenberg, P. F. (1998) Role of the alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH-and hydroperoxide-supported activities Arch. Biochem. Biophys. 350, 324-332
59. Guengerich, F. P. and Bartleson, C. J. (2007) Analysis and characterization of enzymes and nucleic acids. In Principles and Methods of Toxicology (Hayes, A. W., Ed.) pp 1981-2048, CRC Press, Boca Raton, FL.
60. Kadlubar, F. F., Miller, J. A., and Miller, E. C. (1976) Hepatic metabolism of N -hydroxy-N -methyl-4-aminoazobenzene and other N -hydroxy arylamines to reactive sulfuric acid esters Cancer Res. 36, 2350-2359
61. Ogata, Y. and Morimoto, T. (1965) Effects of metallic ions on autoxidation of phenylhydroxylamine to azoxybenzene in methanol J. Org. Chem. 30, 597-600
62. Groskova, D., Stolcova, M., and Hronec, M. (2000) Reaction of N -phenylhydroxylamine in the presence of clay catalysts Catal. Lett. 69, 113-116
63. Ogata, Y., Tsuchida, M., and Takagi, Y. (1957) Kinetics and mechanism of the formation of azoxy compounds J. Am. Chem. Soc. 79, 3397-3401
64. Kim, D. H., Kadlubar, F. F., Teitel, C. H., and Guengerich, F. P. (2004) Formation and reduction of aryl and heterocyclic nitroso compounds and significance in the flux of hydroxylamines Chem. Res. Toxicol. 17, 529-536
65. Bui, P. H., Hsu, E. L., and Hankinson, O. (2009) Fatty acid hydroperoxides support cytochrome P450 2S1-mediated bioactivation of benzo[ a ]pyrene-7,8-dihydrodiol Mol. Pharmacol. 76, 1044-1052
66. Bui, P. H. and Hankinson, O. (2009) Functional characterization of human cytochrome P450 2S1 using a synthetic gene-expressed protein in Escherichia coli Mol. Pharmacol. 76, 1031-1043
67. Kadlubar, F. F., McKee, E. M., and Ziegler, D. M. (1973) Reduced pyridine nucleotide-dependent N -hydroxy amine oxidase and reductase activities of hepatic microsomes Arch. Biochem. Biophys. 156, 46-57
68. Kadlubar, F. F. and Ziegler, D. M. (1974) Properties of a NADH-dependent N -hydroxy amine reductase isolated from pig liver microsomes Arch. Biochem. Biophys. 162, 83-92
69. Bernheim, M. L. and Hochstein, P. (1968) Reduction of hydroxylamine by rat liver mitochondria Arch. Biochem. Biophys. 124, 436-442
70. Bernheim, M. L. (1969) Hydroxylamine reductase of mitochondria Arch. Biochem. Biophys. 134, 408-413
71. Reh, R., Ozols, J., and Clement, B. (2008) Involvement of stearoyl-CoA desaturase in the reduction of amidoxime prodrugs Xenobiotica 38, 1177-1190
72. 2-insensitive NADH-benzamidoxime reductase J. Biol. Chem. 272, 19615-19620
73. Havemeyer, A., Bittner, F., Wollers, S., Mendel, R., Kunze, T., and Clement, B. (2006) Identification of the missing component in the mitochondrial benzamidoxime prodrug-converting system as a novel molybdenum enzyme J. Biol. Chem. 281, 34796-34802
74. Gruenewald, S., Wahl, B., Bittner, F., Hungeling, H., Kanzow, S., Kotthaus, J., Schwering, U., Mendel, R. R., and Clement, B. (2008) The fourth molybdenum containing enzyme mARC: Cloning and involvement in the activation of N -hydroxylated prodrugs J. Med. Chem. 51, 8173-8177
75. Wahl, B., Reichmann, D., Niks, D., Krompholz, N., Havemeyer, A., Clement, B., Messerschmidt, T., Rothkegel, M., Biester, H., Hille, R., Mendel, R. R., and Bittner, F. (2010) Biochemical and spectroscopic characterization of the human mitochondrial amidoxime reducing components hmARC-1 and hmARC-2 suggests the existence of a new molybdenum enzyme family in eukaryotes J. Biol. Chem. 285, 37847-37859
76. 5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans J. Pharmacol. Exp. Ther. 311, 1171-1178
77. 5 Chem. Res. Toxicol. 19, 1366-1373
78. Wislocki, P. G., Miwa, G. T., and Lu, A. Y. H. (1980) Reactions catalyzed by the cytochrome P-450 system. In Enzymatic Basis of Detoxication (Jakoby, W. B., Ed.) Vol. 1, pp 135-182, Academic Press, New York.
79. Testa, B. (1995) Biochemistry of Redox Reactions, Academic Press, London.
80. Vaupel, P. and Mayer, A. (2007) Hypoxia in cancer: Significance and impact on clinical outcome Cancer Metastasis Rev. 26, 225-239
81. Guengerich, F. P. (1983) Oxidation-reduction properties of rat liver cytochromes P-450 and NADPH-cytochrome P-450 reductase related to catalysis in reconstituted systems Biochemistry 22, 2811-2820
82. 5 J. Biol. Chem. 271, 27438-27444
83. Distlerath, L. M., Reilly, P. E. B., Martin, M. V., Davis, G. G., Wilkinson, G. R., and Guengerich, F. P. (1985) Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O -deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism J. Biol. Chem. 260, 9057-9067
84. Liu, T., Smith, G. W., and Rankin, J. T. (1972) Renal pelvic tumor associated with analgesic abuse Can. Med. Assoc. J. 107, 768-771
85. Bengtsson, U., Johansson, S., and Angervall, L. (1978) Malignancies of urinary tract and their relation to analgesic abuse Kidney Int. 13, 107-113
86. Seto, Y. and Guengerich, F. P. (1993) Partitioning between N -dealkylation and N -oxygenation in the oxidation of N, N -dialkylarylamines catalyzed by cytochrome P450 2B1 J. Biol. Chem. 268, 9986-9997
87. Neumann, H. G. (1988) Biomonitoring of aromatic amines and alkylating agents by measuring hemoglobin adducts Int. Arch. Occup. Environ. Health 60, 151-155
88. Jones, C. R. and Sabbioni, G. (2003) Identification of DNA adducts using HPLC-MS/MS following in vitro and in vivo experiments with arylamines and nitroarenes Chem. Res. Toxicol. 16, 1251-1263
89. Green, L. C., Skipper, P. L., Turesky, R. J., Bryant, M. S., and Tannenbaum, S. R. (1984) In vivo dosimetry of 4-aminobiphenyl in rats via a cysteine adduct in hemoglobin Cancer Res. 44, 4254-4259